Paediatrics (RCH) - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 4 of 4
  • Item
    Thumbnail Image
    Stakeholder consultative meeting on prevention and management of childhodd pneumonia and diarrhoea: report, 12-14 October 2021
    WHO, (World Health Organization, 2022-04-04)
    This report summarises the main findings of the stakeholders consultative meeting to present and discuss the WHO commissioned systematic reviews on prevention and management of childhood pneumonia and diarrhoea. The report summarises the key findings of the systematic review, identifies areas to review and update current pneumonia and diarrhoea prevention and management guidelines, highlights issues related to the implementation of pneumonia and diarrhoea interventions, and identifies gaps in knowledge for future research areas for these two childhood illnesses. The report is relevant to the policy-makers, health professionals, academic institutions and NGOs.
  • Item
  • Item
    Thumbnail Image
    WHO consolidated guidelines on tuberculosis – tuberculosis preventive treatment.
    WHO, (World Health Organization, 2020)
    Steve Graham (Center for International Child Health University of Melbourne, Australia) was a member of the External Review Group (ERG) for the 2020 guidelines. Background: About one fourth of the world’s population is estimated to be infected with the tuberculosis (TB) bacterium, and about 5–10% of those infected develop active TB disease in their lifetime. The risk for active TB disease after infection depends on several factors, the most important being the person’s immunological status. TB preventive treatment given to people at highest risk of progressing from TB infection to disease remains a critical activity to achieve the global targets of the End TB Strategy, as reiterated by the UN High Level Meeting on TB in 2018. Delivering treatment effectively and safely necessitates a programmatic approach to implement a comprehensive package of interventions: identifying individuals at highest risk, testing for infection, excluding active TB, choosing the treatment option that is best suited to an individual, managing adverse events, supporting medication adherence and monitoring programmatic performance. The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by matching modules of a consolidated operational handbook. [1] The handbook will provide practical advice on how to put in place the recommendations at the scale needed to achieve national and global impact. The first handbook module in the series will be on the programmatic management of TB preventive treatment and will accompany the 2020 guidelines. Overview: The 18 recommendations on tuberculosis preventive treatment in the 2020 update cover critical steps in programmatic management that follow the cascade of preventive care. The main changes introduced include conditional recommendations for a 1-month daily rifapentine and isoniazid regimen and a 4-month daily rifampicin regimen as alternative treatment options in all TB burden settings. Advice on isoniazid preventive treatment in pregnancy and on the concomitant use of rifapentine and dolutegravir has been updated to reflect the findings from latest studies. The operational limitations that need to be overcome by countries to achieve global targets are highlighted and will be discussed in greater detail in the accompanying operational handbook that is being released concurrently. The guidelines are to be used primarily in national TB and HIV programmes, or their equivalents in ministries of health, and for other policy-makers working on TB and HIV and infectious diseases in public and private sectors and in the community.
  • Item
    Thumbnail Image
    WHO operational handbook on tuberculosis. Module 1: prevention - tuberculosis preventive treatment.
    WHO, (World Health Organization, 2020)
    Steve Graham (Center for International Child Health University of Melbourne, Australia) was a member of the External Review Group (ERG) for the 2020 guidelines. Background: About one fourth of the world’s population is estimated to be infected with the tuberculosis (TB) bacterium, and about 5–10% of those infected develop active TB disease in their lifetime. The risk for active TB disease after infection depends on several factors, the most important being the person’s immunological status. TB preventive treatment given to people at highest risk of progressing from TB infection to disease remains a critical activity to achieve the global targets of the End TB Strategy, as reiterated by the UN High Level Meeting on TB in 2018. Delivering treatment effectively and safely necessitates a programmatic approach to implement a comprehensive package of interventions. The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook will be the first in a modular series of practical guides meant for the implementers of various aspects of the programmatic management TB. Overview: The handbook provides practical advice on how to put in place the WHO recommendations at the scale needed to achieve national and global impact. The chapters cover critical steps in programmatic management of TB preventive treatment following the cascade of preventive care: identifying individuals at highest risk, testing for infection, excluding active TB, choosing the treatment option that is best suited to an individual, managing adverse events, supporting medication adherence and monitoring programmatic performance. The annexes include useful resources such as sample text for advocacy messaging, FAQs on testing for TB infection, considerations for coordination and budgeting for national strategic planning and resource mobilization. Although its focus is on high TB and HIV burden settings, the advice in the handbook is also relevant elsewhere. This book is intended to guide policy-makers within the ministries of health and other institutions, and stakeholders that have an impact on health, including HIV and TB programme managers at national, subnational and district levels; health care workers and staff of development and technical agencies, nongovernmental organizations as well as civil society and community-based organizations involved in supporting TPT services.